Search Results

Editorial [Hot topic: The Role of Pemetrexed in Lung Cancer (Guest Editors: Daoyuan Wang and Jianxing He)]

Authors: Wang, Daoyuan; He, Jianxing

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 1-1(1)

Publisher: Bentham Science Publishers

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

Authors: Chen, Manyin; Shao, Wenlong; He, Jianxing; Wang, Daoyuan

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 29-36(8)

Publisher: Bentham Science Publishers

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

Authors: Ngeow, Joanne; Toh, Chee-Keong

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 61-66(6)

Publisher: Bentham Science Publishers

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications

Authors: Bar-Sela, G.; Epelbaum, R.; Schaffer, M.

Source: Current Medicinal Chemistry, Volume 17, Number 3, January 2010 , pp. 190-197(8)

Publisher: Bentham Science Publishers

Analytical Strategies for Characterizing Chemotherapy Diffusion with Patient-Level Population-Based Data

Authors: Sima, Cami S.; Panageas, Katherine S.; Heller, Glenn; Schrag, Deborah

Source: Applied Health Economics and Health Policy, Volume 8, Number 1, 1 March 2010 , pp. 37-51(15)

Publisher: Adis International

Cisplatin + pemetrexed as first-line therapy for advanced NSCLC

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 593, 2009-12-12 , pp. 5-5(1)

Publisher: Adis International

Poly(ADP-ribose) Glycohydrolase Deficiency Sensitizes Mouse ES Cells to DNA Damaging Agents

Authors: Fujihara, H.; Ogino, H.; Maeda, D.; Shirai, H.; Nozaki, T.; Kamada, N.; Jishage, K.; Tanuma, S.; Takato, T.; Ochiya, T.; Sugimura, T.; Masutani, M.

Source: Current Cancer Drug Targets, Volume 9, Number 8, December 2009 , pp. 953-962(10)

Publisher: Bentham Science Publishers

Gemcitabine and vinorelbine therapy for patients with Hodgkin lymphoma

Authors: Al-Rahawan, Mohamad M; de Alarcón, Pedro A

Source: Pediatric Health, Volume 3, Number 6, December 2009 , pp. 525-532(8)

Publisher: Future Medicine

Therapy of Sézary syndrome

Authors: Kirby, Joslyn S; Kim, Ellen J; Rook, Alain H

Source: Expert Review of Dermatology, Volume 4, Number 6, December 2009 , pp. 567-579(13)

Publisher: Expert Reviews

Gemcitabine: Hepatitis in an elderly patient: case report

Source: Reactions, Volume 1, Number 1281, 2009-12-05 , pp. 17-18(2)

Publisher: Adis International

The cost utility of pemetrexed as first-line therapy for advanced non-small cell lung cancer appears to be hindered by poor basal QOL

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 8-8(1)

Publisher: Adis International

Gemcitabine: Reversible posterior leukoencephalopathy syndrome: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 18-18(1)

Publisher: Adis International

Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer

Authors: Matsuzaki, Taro; Yashiro, Masakazu; Kaizaki, Ryoji; Yasuda, Koichi; Doi, Yosuke; Sawada, Tetsuji; Ohira, Masaichi; Hirakawa, Kosei

Source: Cancer Science, Volume 100, Number 12, December 2009 , pp. 2402-2410(9)

Publisher: Blackwell Publishing

The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple-negative Breast Cancer

Authors: Koo, Ja Seung; Jung, Woohee; Jeong, Joon

Source: Japanese Journal of Clinical Oncology, Volume 39, Number 9, 11 September 2009 , pp. 560-568(9)

Publisher: Oxford University Press

A Phase I Study of Gemcitabine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2

Authors: Kim, Young Hak; Kubota, Kaoru; Goto, Koichi; Yoh, Kiyotaka; Niho, Seiji; Ohmatsu, Hironobu; Saijo, Nagahiro; Nishiwaki, Yutaka

Source: Japanese Journal of Clinical Oncology, Volume 39, Number 9, 11 September 2009 , pp. 576-581(6)

Publisher: Oxford University Press

Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer

Authors: Nelson, Amy R.; Davydova, Julia; Curiel, David T.; Yamamoto, Masato

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2181-2187(7)

Publisher: Blackwell Publishing

HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment

Authors: Maréchal, Raphaël; Van Laethem, Jean-Luc

Source: Expert Review of Anticancer Therapy, Volume 9, Number 10, October 2009 , pp. 1439-1441(3)

Publisher: Expert Reviews

Novel agents for the treatment of adenocarcinoma of the pancreas

Authors: Mackenzie, R Pamela; McCollum, A David

Source: Expert Review of Anticancer Therapy, Volume 9, Number 10, October 2009 , pp. 1473-1485(13)

Publisher: Expert Reviews

Gemcitabine: Haemolytic uraemic syndrome, and fatal heart failure associated with atrial fibrillation: 2 case reports

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 22-23(2)

Publisher: Adis International

Genetic factors influencing cytarabine therapy

Author: Lamba, Jatinder K

Source: Pharmacogenomics, Volume 10, Number 10, October 2009 , pp. 1657-1674(18)

Publisher: Future Medicine